Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma.

about

Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies Novel agents and new therapeutic approaches for treatment of multiple myeloma.

P2860

Q35547153-201C503A-C3E5-4DCA-B6AE-661EB4A41052 Q38261677-4298B99A-853A-4509-A082-7B51DAE465B7

P2860

Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma.

Item

http://www.wikidata.org/entity/Q36014687

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Induction therapy and stem cel ...... ly diagnosed multiple myeloma.

@ast

Induction therapy and stem cel ...... ly diagnosed multiple myeloma.

@en

type

Item

label

Induction therapy and stem cel ...... ly diagnosed multiple myeloma.

@ast

Induction therapy and stem cel ...... ly diagnosed multiple myeloma.

@en

prefLabel

Induction therapy and stem cel ...... ly diagnosed multiple myeloma.

@ast

Induction therapy and stem cel ...... ly diagnosed multiple myeloma.

@en

P1476

Induction therapy and stem cel ...... ly diagnosed multiple myeloma.

@en

P2093

Angelo Vacca

http://www.w3.org/2001/XMLSchema#string

Antonia Reale

http://www.w3.org/2001/XMLSchema#string

Antonio Giovanni Solimando

http://www.w3.org/2001/XMLSchema#string

Giuseppe Iodice

http://www.w3.org/2001/XMLSchema#string

Giuseppe Mangialardi

http://www.w3.org/2001/XMLSchema#string

Lucia Gelao

http://www.w3.org/2001/XMLSchema#string

Michele Moschetta

http://www.w3.org/2001/XMLSchema#string

Roberto Ria

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.

Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromes.

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Antitumor activity of thalidomide in refractory multiple myeloma.

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

P304

607260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/607260

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225376598

http://www.w3.org/2001/XMLSchema#string

P698

22701493

http://www.w3.org/2001/XMLSchema#string

P932

3369512

http://www.w3.org/2001/XMLSchema#string

Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma.

about

P2860

P2860

Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932